EP2887961

NEP INHIBITORS FOR TREATING DISEASES CHARACTERIZED BY ATRIAL ENLARGEMENT OR REMODELING

  • :
    EP einkaleyfi: Þýðing ekki lögð inn
  • :
    22.8.2013
  • :
    28.4.2021
  • :
    13750725.7
  • :
    21.8.2033
  • :
    NEP INHIBITORS FOR TREATING DISEASES CHARACTERIZED BY ATRIAL ENLARGEMENT OR REMODELING

22.8.2013
28.4.2021
  • :
    Novartis AG
  • :
    Lichtstrasse 35, 4056 Basel, CH
  • :
    SCHUMACHER, Christoph
  • :
    CH-4002 Basel, CH
  • :
    HOLBRO, Thomas
  • :
    CH-4002 Basel, CH
  • :
    201261692911 P
  • :
    24.8.2012
  • :
    US
  • :
    EP2013067472
  • :
    22.8.2013
  • :
    A61K 45/06, A61K 31/4192, A61K 31/216, A61K 31/194, A61K 31/197, A61P 9/00, A61P 9/04, A61P 9/10, A61P 9/06, A61P 43/00, A61P 9/12, A61K 31/41, A61P 7/00